Please login to the form below

Not currently logged in
Email:
Password:

PPD expands global product department with new therapeutic area heads

Selects Daniel Burch, Puneet Mohan and Alan Solinger to fill the positions

PPD Daniel BurchContract research organisation (CRO) PPD has appointed Daniel Burch, Puneet Mohan and Alan Solinger to fill three new therapeutic area head positions.

The move expands the company's expertise in CNS, cardiovascular/metabolism and rheumatology/immunology and swells its global product department team.

Daniel Burch (pictured top right) joins PPD from CeNeRx BioPharma, where he was executive VP of R&D and chief medical officer. Prior to joining CeNeRx, Burch was at GlaxoSmithKline (GSK), where he most recently served as senior VP and head of GSK's neurosciences medicine development centre.

PPD Mohan Puneet

He has 20 years of experience in general management, global drug development, global medical affairs and business development.

Puneet Mohan (left) comes to PPD from Bristol-Myers Squibb, where he most recently served as executive director of global clinical development and global clinical leader for Eliquis (apixaban).

He held this role for eight of his 29-year medical career and prior to serving at BMS, Mohan was with Bayer.

PPD Alan SolingerAlan Solinger's (bottom right) medical career covers 30 years and he joins PPD from Californian biotech company Xoma, where he served as vice president of clinical immunology.

PPD's global product development team of six therapeutic area heads is managed by its global head of medical affairs Rob Dow.

"These experts have held senior leadership roles in top biopharma companies, and their expertise will bring added strategic value to our clients. I am pleased to welcome them to our team," he said.

Burch, Mohan and Solinger join PPD's existing therapeutic area heads of Carol Olson (infectious diseases), Dirk Reitsma (oncology) and Peter Summerfield (respiratory).

22nd February 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics